Acute Care
What we do

We develop, manufacture and distribute the highest quality, and most innovative systems and data management solutions for Acute Care Diagnostics, spanning Blood Gas, Whole Blood Hemostasis and Bleeding Management. Our solutions help hospitals, hospital networks and commercial laboratories ensure quality results and enhance efficiency.

How we power patient care

As a market leader in Acute Care Diagnostics, our portfolio of integrative solutions delivers fast, actionable, lab-quality results at the point-of-care. Crucial to ensuring optimal patient management, our innovative whole blood, cartridge-based systems are simple to use and quality-assured. Accurate, reliable results, received quickly, help inform key patient management decisions clinicians make every day.

Acute Care


Launch of new flagship product and growth across all product lines
For Acute Care, 2024 was a year of excellent business growth across product lines and geographies, coupled with the commercialization of key innovations. Of note, we commercially launched our new flagship product, the GEM Premier 7000 with iQM3, a breakthrough in blood gas testing, in the United States. This system offers hemolysis detection at the point of care, for the very first time. This significant innovation has the potential to enhance both efficiency and patient care in hospitals around the world, as it continues to be commercialized in hospitals around the world.
Finally, in December, we opened a new building, expanding our innovation capabilities in Specialized Diagnostics, at our Hemostasis and Acute Care Diagnostics Technology Center in Bedford, MA. This adds 105,000 additional square feet and represents an investment of more than US $50 million. It also increases our capacity from 1,200 employees today, to 2,000 employees, allowing growth in our Innovation program for several years to come.